Catian, Kurth Nathan G.
HRN: 23-06-01 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/15/2023
CEFUROXIME 750MG (VIAL)
05/15/2023
05/21/2023
IV DRIP
400 Mg
Q8
UTI
Waiting Final Action
Indication: Empiric Type of Infection: Reproductive Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes